{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:05:56Z","timestamp":1793833556153,"version":"4.6.1"},"reference-count":48,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,2,15]]},"DOI":"10.2169\/internalmedicine.4203-24","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T18:10:58Z","timestamp":1723054258000},"page":"503-517","source":"Crossref","is-referenced-by-count":10,"title":["Management of the Diagnosis and Treatment of Pneumonia in an Aging Society"],"prefix":"10.2169","volume":"64","author":[{"given":"Kazuhiro","family":"Yatera","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Director-General for Statistics, Information Policy and Industrial Relations, Ministry of Health, Labour and Welfare. Vital Statistics of Japan 2021 [Internet]. [cited 2024 Mar 20]. Available from: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/houkoku21\/dl\/all.pdf (in Japanese)"},{"key":"2","unstructured":"2. Ministry of Health, Labour and Welfare. Japan White Paper and Annual Reports (in Japanese) [Internet]. [cited 2024 Mar 20]. Available from: https:\/\/www.mhlw.go.jp\/wp\/hakusyo\/kousei\/16\/dl\/all.pdf"},{"key":"3","unstructured":"3. The Japanese Respiratory Society. [Guidelines for the management adults with community-acquired pneumonia]. The Japanese Respiratory Society, Tokyo, 2000 (in Japanese)."},{"key":"4","unstructured":"4. The Japanese Respiratory Society. [Guidelines for the management adults with hospital-acquired pneumonia]. The Japanese Respiratory Society, Tokyo, 2002 (in Japanese)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kohno S, Imamura Y, Shindo Y, et al. Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [complete translation]. Respir Investig 51: 103-126, 2013.","DOI":"10.1016\/j.resinv.2012.11.001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: 388-416, 2005.","DOI":"10.1164\/rccm.200405-644ST"},{"key":"7","unstructured":"7. The Japanese Respiratory Society. The JRS Guidelines for the Management of Pneumonia in Adults 2017. Medical View, Tokyo, 2017 (in Japanese)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200: e45-e67, 2019.","DOI":"10.1164\/rccm.201908-1581ST"},{"key":"9","unstructured":"9. The Japanese Respiratory Society. The JRS Guidelines for the Management of Pneumonia in Adults 2024. Medical View, Tokyo, 2024 (in Japanese)."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655, 1992.","DOI":"10.1378\/chest.101.6.1644"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Komiya K, Rubin BK, Kadota JI, et al. Prognostic implications of aspiration pneumonia in patients with community acquired pneumonia: a systematic review with meta-analysis. Sci Rep 6: 38097, 2016.","DOI":"10.1038\/srep38097"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Taylor JK, Fleming GB, Singanayagam A, Hill AT, Chalmers JD. Risk factors for aspiration in community-acquired pneumonia: analysis of a hospitalized UK cohort. Am J Med 126: 995-1001, 2013.","DOI":"10.1016\/j.amjmed.2013.07.012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yatera K, Mukae H. <i>Corynebacterium<\/i> species as one of the major causative pathogens of bacterial pneumonia. Respir Investig 58: 131-133, 2020.","DOI":"10.1016\/j.resinv.2020.01.008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miyashita N, Nakamori Y, Ogata M, et al. Clinical features of nursing and healthcare-associated pneumonia due to COVID-19. J Infect Chemother 28: 902-906, 2022.","DOI":"10.1016\/j.jiac.2022.03.010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jain S, Self WH, Wunderink RG, et al; the CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373: 415-427, 2015.","DOI":"10.1056\/NEJMc1511751"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Horita N, Otsuka T, Haranaga S, et al. Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 Update. Sci Rep 5: 14061, 2015.","DOI":"10.1038\/srep14061"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Wan YD, Sun TW, Liu ZQ, Zhang SG, Wang LX, Kan QC. Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis. Chest 149: 209-219, 2016.","DOI":"10.1378\/chest.15-1733"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Briel M, Spoorenberg SMC, Snijders D, et al; the Ovidius Study Group, Capisce Study Group, STEP Study Group. Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis. Clin Infect Dis 66: 346-354, 2018.","DOI":"10.1093\/cid\/cix801"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H. Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients. Eur Respir J 45: 463-472, 2015.","DOI":"10.1183\/09031936.00081514"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lloyd M, Karahalios A, Janus E, et al; the Improving Evidence-Based Treatment Gaps and Outcomes in Community-Acquired Pneumonia (IMPROVE-GAP) Implementation Team at Western Health. Effectiveness of a bundled intervention including adjunctive corticosteroids on outcomes of hospitalized patients with community-acquired pneumonia: a stepped-wedge randomized clinical trial. JAMA Intern Med 179: 1052-1060, 2019.","DOI":"10.1001\/jamainternmed.2019.1438"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tachiwada T, Noguchi S, Muramatsu K, et al. Effects of additive corticosteroid therapy on 90-day survival in patients with community-onset pneumonia. J Infect Chemother 28: 496-503, 2022.","DOI":"10.1016\/j.jiac.2021.12.012"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yoneyama T, Yoshida M, Ohrui T, et al; Members of the Oral Care Working Group. Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc 50: 430-433, 2002.","DOI":"10.1046\/j.1532-5415.2002.50106.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Suzuki M, Dhoubhadel BG, Ishifuji T, et al; the Adult Pneumonia Study Group-Japan (APSG-J). Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. Lancet Infect Dis 17: 313-321, 2017.","DOI":"10.1016\/S1473-3099(17)30049-X"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Shimbashi R, Suzuki M, Chang B, et al; the Adult IPD Study Group. Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in adults, Japan, 2013-2017. Emerg Infect Dis 26: 2378-2386, 2020.","DOI":"10.3201\/eid2610.191531"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 372: 1114-1125, 2015.","DOI":"10.1056\/NEJMoa1408544"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Platt HL, Cardona JF, Haranaka M, et al. A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE). Vaccine 40: 162-172, 2022.","DOI":"10.1016\/j.vaccine.2021.08.049"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. McLean HQ, Petrie JG, Hanson KE, et al. Interim estimates of 2022-23 seasonal influenza vaccine effectiveness - Wisconsin, October 2022-February 2023. MMWR Morb Mortal Wkly Rep 72: 201-205, 2023.","DOI":"10.15585\/mmwr.mm7208a1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Papi A, Ison MG, Langley JM, et al; the AReSVi-006 Study Group. Respiratory syncytial virus prefusion F protein vaccine in older adults. N Engl J Med 388: 595-608, 2023.","DOI":"10.1056\/NEJMoa2209604"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gupta AB, Flanders SA, Petty LA, et al. Inappropriate diagnosis of pneumonia among hospitalized adults. JAMA Intern Med 184: 548-556, 2024.","DOI":"10.1001\/jamainternmed.2024.0077"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tsutsui H, Ide T, Ito H, et al; the Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS\/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure. Circ J 85: 2252-2291, 2021.","DOI":"10.1253\/circj.CJ-21-0431"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 354: 2317-2327, 2006.","DOI":"10.1056\/NEJMoa052367"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sostman HD, Stein PD, Gottschalk A, Matta F, Hull R, Goodman L. Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study. Radiology 246: 941-946, 2008.","DOI":"10.1148\/radiol.2463070270"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Pfeil A, Schmidt P, Hermann R, B\u00f6ttcher J, Wolf G, Hansch A. Parenchymal and pleural findings in pulmonary embolism visualized by multi-channel detector computed tomography. Acta Radiol 51: 775-781, 2010.","DOI":"10.3109\/02841851.2010.492238"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yu X, Zhang S, Xu J, et al. Nomogram using CT radiomics features for differentiation of pneumonia-type invasive mucinous adenocarcinoma and pneumonia: multicenter development and external validation study. AJR Am J Roentgenol 220: 224-234, 2023.","DOI":"10.2214\/AJR.22.28139"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Cleverley JR, Screaton NJ, Hiorns MP, Flint JD, M\u00fcller NL. Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol 57: 292-299, 2002.","DOI":"10.1053\/crad.2001.0792"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Basarakodu KR, Aronow WS, Nair CK, et al. Differences in treatment and in outcomes between idiopathic and secondary forms of organizing pneumonia. Am J Ther 14: 422-426, 2007.","DOI":"10.1097\/01.pap.0000249905.63211.a1"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Cordier JF. Organising pneumonia. Thorax 55: 318-328, 2000.","DOI":"10.1136\/thorax.55.4.318"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT Features of Viral Pneumonia. Radiographics 38: 719-739, 2018.","DOI":"10.1148\/rg.2018170048"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Zhao X, Liu B, Yu Y, et al. The characteristics and clinical value of chest CT images of novel coronavirus pneumonia. Clin Radiol 75: 335-340, 2020.","DOI":"10.1016\/j.crad.2020.03.002"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Yamasaki K, Yatera K. Key Points of Respiratory Care Required for General Physician. Topics: VII. Management of nursing and healthcare-associated pneumonia. Nihon Naika Gakkai Zasshi (J Jpn Soc Int Med) 110: 1106-1114, 2021 (in Japanese).","DOI":"10.2169\/naika.110.1106"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Greene R. The radiological spectrum of pulmonary aspergillosis. Med Mycol 43: S147-S154, 2005.","DOI":"10.1080\/13693780500064771"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Franquet T, M\u00fcller NL, Oikonomou A, Flint JD. Aspergillus infection of the airways: computed tomography and pathologic findings. J Comput Assist Tomogr 28: 10-16, 2004.","DOI":"10.1097\/00004728-200401000-00002"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Fox DL, M\u00fcller NL. Pulmonary cryptococcosis in immunocompetent patients: CT findings in 12 patients. AJR Am J Roentgenol 185: 622-626, 2005.","DOI":"10.2214\/ajr.185.3.01850622"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Wang DX, Zhang Q, Wen QT, et al. Comparison of CT findings and histopathological characteristics of pulmonary cryptococcosis in immunocompetent and immunocompromised patients. Sci Rep 12: 5712, 2022.","DOI":"10.1038\/s41598-022-09794-6"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller L. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 32: 1680-1684, 1994.","DOI":"10.1128\/jcm.32.7.1680-1684.1994"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis 32: 87-93, 2015.","DOI":"10.1016\/j.ijid.2014.12.007"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. van der Heijden YF, Maruri F, Blackman A, et al. Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death. Int J Tuberc Lung Dis 16: 1162-1167, 2012.","DOI":"10.5588\/ijtld.12.0046"},{"key":"48","unstructured":"48. Ebrahimian R, Souri Z, Feizkhah A, et al. Evaluation of the spiral chest CT scan findings in patients with multiple trauma. Bull Emerg Trauma 11: 19-25, 2023."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/4\/64_4203-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T22:32:16Z","timestamp":1739572336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/4\/64_4203-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4203-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"article-number":"4203-24"}}